Insider Trading March 12, 2026

Covista Lead Independent Director Purchases $3.64 Million in Stock Amid Company Moves

Michael W Malafronte expands personal and trust holdings while Covista completes $510M refinancing and sits below estimated fair value

By Maya Rios CVSA
Covista Lead Independent Director Purchases $3.64 Million in Stock Amid Company Moves
CVSA

Michael W Malafronte, Covista Inc's lead independent director, acquired common shares in three transactions on March 10-11, 2026, totaling $3,635,413. The purchases increased his direct stake to 113,205 shares and boosted holdings of the Michael W Malafronte 2016 Gift Trust to 25,395 shares. The buys occurred as Covista shares have fallen 26% over six months and after the company arranged $510 million in new term loans maturing in 2033.

Key Points

  • Insider purchases increased direct and trust holdings for Covista's lead independent director, totaling $3,635,413 across March 10-11, 2026.
  • InvestingPro data shows Covista's stock down 26% over six months and trading below its Fair Value with a P/E of 14.76 and market cap of $3.49 billion.
  • Covista refinanced with $510 million in 2026 Term Loans maturing March 2, 2033, administered by Morgan Stanley Senior Funding, Inc., at a reduced interest rate margin.

Michael W Malafronte, who serves as lead independent director at Covista Inc (OTC:CVSA), reported three purchases of common stock executed on March 10 and March 11, 2026, that together amount to $3,635,413. The transactions took place at prices ranging from $100.8647 to $100.9382, and were split between shares bought in his own name and shares acquired in his capacity as trustee.

In the transactions executed at per-share prices between $100.8647 and $100.9382, Malafronte purchased 11,841 shares directly for a combined $1,194,378. After that acquisition, his personal, direct holdings rose to 113,205 shares.

Separately, acting as trustee for the Michael W Malafronte 2016 Gift Trust, he acquired 15,305 shares on March 10 and another 8,890 shares on March 11. Those trust purchases were made at the same per-share price points of $100.8647 and $100.9382 respectively, and brought the trust's total to 25,395 shares.

The insider buying comes at a time when the company's stock has declined 26% over the prior six months, according to InvestingPro data. InvestingPro analysis cited in the filing indicates Covista is trading below its Fair Value estimate. The company is reported to trade at a price-to-earnings ratio of 14.76 and a market capitalization of $3.49 billion.

Beyond the insider activity and valuation commentary, Covista has recently refinanced a portion of its debt. The company secured new term loans totaling $510 million - identified as the 2026 Term Loans - which mature on March 2, 2033. These replacement loans carry a lower interest rate margin, and Morgan Stanley Senior Funding, Inc. served as administrative agent for the refinancing.

The filing does not include commentary from Malafronte about the rationale for the purchases. The documentation simply records the acquisition details, pricing, and resulting ownership levels for both the director personally and for the named trust.

Also noted in the same filing cycle was an unrelated earnings update from Adtalem Global Education Inc., which reported second-quarter fiscal 2026 results that exceeded analyst expectations. Adtalem posted earnings per share of $2.43 versus a $2.19 forecast and revenue of $503.4 million against a predicted $490.75 million, producing a 10.96% earnings surprise.

These developments - director purchases, a sizable refinancing transaction, and outside-sector earnings beats - were disclosed together in filings covering the period around March 10-11, 2026.


Summary

Lead Independent Director Michael W Malafronte purchased $3,635,413 of Covista common stock in three trades on March 10-11, 2026. The transactions increased his direct holdings to 113,205 shares and raised the Michael W Malafronte 2016 Gift Trust stake to 25,395 shares. The stock had fallen 26% over six months and InvestingPro indicates the company is trading below Fair Value. Covista also completed a $510 million refinancing in the form of 2026 Term Loans due March 2, 2033, with Morgan Stanley Senior Funding, Inc. as administrative agent.

Key points

  • Insider purchases: Malafronte bought shares personally (11,841 shares) and for his 2016 Gift Trust (24,195 shares combined across two dates), totaling $3,635,413.
  • Valuation and market context: Covista shares are down 26% over six months; InvestingPro flags the stock as below Fair Value, with a P/E of 14.76 and a market cap of $3.49 billion.
  • Company financing: Covista arranged $510 million in new term loans maturing March 2, 2033, at a reduced margin, with Morgan Stanley Senior Funding, Inc. as administrative agent.

Risks and uncertainties

  • Share-price volatility - the stock has declined 26% over six months, indicating market volatility that could affect investor returns and sentiment in the short term.
  • Refinancing outcomes - while the new $510 million term loans carry a lower margin, refinancing terms and future interest-rate movements could influence Covista's financing costs and balance-sheet flexibility.
  • Limited disclosure on intent - the filings record purchases and resulting holdings but do not provide a stated rationale from the director, leaving interpretation of motives open.

Risks

  • Ongoing share-price volatility following a 26% decline over six months could affect investor returns and market perception.
  • Refinancing risk tied to future interest-rate movements and covenant terms could influence Covista's cost of capital and balance-sheet flexibility.
  • The filing does not disclose the director's motivations, leaving uncertainty about whether the purchases signal long-term conviction or other objectives.

More from Insider Trading

RENN Fund President Murray Stahl Adds 1,134 Shares of RCG Mar 12, 2026 Williams Companies SVP Disposes $547,807 in Stock as Shares Trade Near 52-Week High Mar 12, 2026 SEI Investments Chairman Emeritus Disposes $5.0M in Shares Over Two Days Mar 12, 2026 Hillman Solutions CLO Disposes of $97,855 in Stock; Company Posts Mixed Q4 Results Mar 12, 2026 Hillman Solutions Division President Sells $12,028 in Stock; Company Faces Revenue Shortfall Mar 12, 2026